Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Endocrinology

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.1.06522PMID 16731793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Islet adaptation to insulin resistance: mechanisms and implications for intervention

  2005cited by this paper
• β-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology*

  2004cited by this paper
• The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

  2004cited by this paper
• Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.

  2004cited by this paper
• Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.

  2004cited by this paper
• Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects.

  2004cited by this paper
• GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.

  2004cited by this paper
• Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea.

  2003cited by this paper
• Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea

  2003cited by this paper
• Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.

  2003cited by this paper
• Forskolin suppresses insulin gene transcription in islet beta-cells through a protein kinase A-independent pathway.

  2003cited by this paper
• Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.

  2003cited by this paper
• Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic β-Cell Exocytosis and Release of Insulin*

  2002cited by this paper
• Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.

  2002cited by this paper
• Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

  2002cited by this paper
• Cyclic nucleotide phosphodiesterases: relating structure and function.

  2001cited by this paper
• Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

  2001cited by this paper
• Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.

  2001cited by this paper
• Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells

  2000cited by this paper
• Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

  2000cited by this paper
• Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

  2000cited by this paper
• cAMP-GEFII is a direct target of cAMP in regulated exocytosis

  2000cited by this paper
• Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.

  2000cited by this paper
• Free fatty acids and pathogenesis of type 2 diabetes mellitus.

  2000cited by this paper
• Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice.

  2000cited by this paper
• Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells1

  2000cited by this paper
• Cre‐mediated recombination in the pituitary gland

  2000cited by this paper
• Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3)

  2000cited by this paper
• Effect of tension on contraction-induced glucose transport in rat skeletal muscle.

  1999cited by this paper
• The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion*

  1999influential reference
• Cyclic Nucleotide Phosphodiesterases (PDEs): Diverse Regulators of Cyclic Nucleotide Signals and Inviting Molecular Targets for Novel Therapeutic Agents

  1999cited by this paper
• Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1

  1998cited by this paper
• Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III.

  1997cited by this paper
• The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat.

  1997cited by this paper
• Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells

  1997cited by this paper
• Effects of type‐selective phosphodiesterase inhibitors on glucose‐induced insulin secretion and islet phosphodiesterase activity

  1995influential reference
• Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.

  1995influential reference
• A Simple Free Fat Cell Bioassay for Insulin

  1974cited by this paper

• A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus.

  2024cites this paper
• Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease

  2024cites this paper
• Kefir protects the liver against high fructose corn syrup induced phosphodiesterase hyperactivity

  2022cites this paper
• Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice

  2022cites this paper
• Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

  2021cites this paper
• Role of Phosphodiesterase in the Biology and Pathology of Diabetes

  2020influential citation
• Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells

  2019cites this paper
• A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling

  2019cites this paper
• Chapter 13 Cyclic AMP Signalling in Pancreatic Islets

  2018cites this paper
• Baicalin regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production

  2018cites this paper
• Berberine, Quercetin and O-Coumaric Acid Phytochemicals Ameliorate the Impact of Experimentally Fed High-Fat/High-Sucrose Diet on Pancreas Β-Cells and Glycemic Control Indices

  2016cites this paper
• Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity

  2014cites this paper
• Studies in beta cells and adipocytes in the context of obesity and T2D - focusing on PDE3B, OPN and SCFAs

  2014cites this paper
• Cyclic nucleotide phosphodiesterase 3B is connected to osteopontin and protein kinase CK2 in pancreatic β-cells *

  2013cites this paper
• Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model.

  2013cites this paper
• Cyclic nucleotide phosphodiesterase 3 B is connected to osteopontin and protein kinase CK 2 in pancreatic β-cells *

  2013cites this paper
• Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase

  2012cites this paper
• From PDE3B to the regulation of energy homeostasis.

  2011cites this paper
• Characterization of cAMP-Specific Phosphodiesterase-4 (R)-[11C]Rolipram Small Animal Positron Emission Tomography and Application in a Streptozotocin-Induced Model of Hyperglycemia

  2011cites this paper
• PDE inhibitors: a new approach to treat metabolic syndrome?

  2011cites this paper
• Effect of Different Obesogenic Diets on Pancreatic Histology in Ossabaw Miniature Swine

  2011cites this paper
• Cyclic AMP Signalling in Pancreatic Islets

  2010cites this paper
• Expression and Regulation of Cyclic Nucleotide Phosphodiesterases in Human and Rat Pancreatic Islets

  2010cites this paper
• A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet

  2010cites this paper
• Cyclic AMP signaling in pancreatic islets.

  2010cites this paper
• cAMP/cGMP Dual-Specificity Phosphodiesterases

  2010cites this paper
• Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes.

  2009cites this paper
• Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose.

  2008cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas II.

  2007cites this paper
• Beta-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin.

  2007cites this paper
• Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiesterase 3B (PDE3B) and its interaction with PKB.

  2007cites this paper
• Is there a role of pancreatic steatosis together with hypertrigliceridemia on the pathogenesis of diabetes in a patient with type 2 diabetes mellitus?

  2007cites this paper
• Ke fi r protects the liver against high fructose corn syrup induced phosphodiesterase hyperactivity

  year unknowncites this paper